This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Salvianolate for treatment of cerebral ischemia-reperfusion injuries

October 25th, 2013
Salvianolate for treatment of cerebral ischemia-reperfusion injuries
Brown cells are terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells undergoing apoptosis (× 400). Credit: Neural Regeneration Research

Salvianolic acid B, also called salvia magnesium acetate, is a phenolic acid compound composed of three Danshensu units and one molecule of caffeic acid. Salvianolic acid B exerts strong resistance to oxidative stress and inflammatory reaction, and improves energy metabolism against cerebral ischemia-reperfusion injuries.

Dr. Wei Lu and his team from the Second Xiangya Hospital, Central South University, China found that administration of salvianolate during reperfusion after ischemia appears to attenuate brain tissue damage and inhibit neuronal apoptosis by increasing heat shock protein 22 and phosphorylated protein kinase B expression.

These findings were published in the Neural Regeneration Research (Vol. 8, No. 25, 2013).

More information:
"Salvianolate increases heat shock protein expression in a cerebral ischemia-reperfusion injury model" by Jinnan Zhang, Wei Lu, Qiang Lei, Xi Tao, Hong You, Pinghui Xie (Department of Neurology, Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China) Zhang JN, Lu W, Lei Q, Tao X, You H, Xie PH. Salvianolate increases heat shock protein expression in a cerebral ischemia-reperfusion injury model. Neural Regen Res. 2013;8(25):2327-2335.

Provided by Neural Regeneration Research

Citation: Salvianolate for treatment of cerebral ischemia-reperfusion injuries (2013, October 25) retrieved 30 November 2024 from https://sciencex.com/wire-news/144156817/salvianolate-for-treatment-of-cerebral-ischemia-reperfusion-inju.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.